Harmony Biosciences CMO Budur Kumar disposes of USD 1.43 million in common shares
Reuters2026/09/09 21:13- Harmony Biosciences Chief Medical Officer Budur Kumar cut his stake to 13,115 common shares in transactions dated Sept. 4-8.
- Disposed of 33,954 shares at weighted-average prices of USD 41.98 to USD 43.1 per share.
- Exercised stock options for 22,954 shares at USD 30.69 and USD 30.27 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lazard paper warns global supply chains face O-ring-style single-point failures amid geopolitics
Andalan Perkasa Abadi says unaware of material information behind NASA share volatility

Massive Buyback Faces "Cold Reception"! U.S. Treasury Bond Purchase Plan Hits a Wall, Liquidity Tool Risks Becoming Ineffective
The US Treasury's expanded repo operations faced a record-low subscription ratio, highlighting a bottleneck in long-term bond market absorption, which may force officials to further cut issuance of the less liquid 20-year US Treasury bonds.
